This article is only available in the PDF format. Download the PDF to view the article, as well as its associated figures and tables.
—Allow me to call your attention to a few misleading statements in the issue of The Journal, on page 637, in the letter from London. Your correspondent speaks of two new salicylates attracting attention, or being recently introduced into therapeutics, namely: salicylate of mercury and of lithia (lithium). It is especially to the latter I beg to call your attention.1. The lithium salicylate (LiO, HO, C14, H4, O4, HO.), is not a comparatively new preparation; it is officinal in the U. S. P. of 1880, and has been extensively used both on the Continent and in this country in doses ranging from 1 to 4 grams in 24 hours, as a remedy for rheumatism, especially of a subacute or chronic type, and also in gouty diathesis.2. It is not insoluble, being instead deliquescent, and to keep it, it is necessary to use a
Fliesburg OA. SALICYLATE OF LITHIUM.. JAMA. 1887;IX(23):734. doi:10.1001/jama.1887.02400220030011
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: